InsidersTradesSigma
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Insider track record
OtherDisclosed buys
1
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the detailed record of transactions filed by Shakespeare William, Autre. Director active across 1 company, notably Theseus Pharmaceuticals, Inc.. In total, 2 disclosures have been published. Split: 1 buy · 0 sell. Total volume traded: €9k. Activity tracked since 12 October 2021. The latest transaction was disclosed on 6 November 2023 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Declarations2 total
251,084 shares@ US$0.3281.2% of flowCommon StockSEC:0001745020-23-000060:0
625 shares@ US$16.0050.0% of flowCommon StockSEC:0000899243-21-040253:0
Canonical exit: 10 Jan 2022 (T+90)
2 of 2 declarations
About Shakespeare William
William Shakespeare is associated with Theseus Pharmaceuticals, Inc. His role is noted as 'See Remarks', indicating involvement in specific activities or projects within the company.
